Croban’s Pfizer PFE Stock Holding History

Croban’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,245	Closed	-$617K	–	85
2025 Q3	$617K	Sell	24,245 -1,440	-6%	-$35.5K	0.41%	67
2025 Q2	$622K	Sell	25,685 -2,528	-9%	-$59K	0.53%	64
2025 Q1	$715K	Buy	28,213 +2,839	+11%	+$74.3K	0.66%	65
2024 Q4	$673K	Buy	+25,374	New	+$688K	0.66%	65
2023 Q4	$673K	Buy	+25,374	New	+$767K	0.67%	64

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Croban's PFE Position: Q4 2025 in Review

Croban sold out of Pfizer (PFE) in Q4 2025, closing a stake of 24,245 shares — an estimated $617K sold.

Croban first reported a position in PFE in Q4 2023 and held it in 5 quarters. The position peaked at $715K in Q1 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Croban reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Croban sold 24,245 Pfizer shares in Q4 2025, an estimated $617K.
Croban first reported a position in Pfizer in Q4 2023 and held it in 5 quarters.
Croban's Pfizer position peaked at $715K in Q1 2025.
2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Croban's 13F filing for Q4 2025, filed 13 Feb 2026.